- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
-
ADR Overview - Which Stocks Look Good, Which Don't
-
Emerging Market Biotechs: Multiple Under-Appreciated Stocks
-
20 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
-
Biovail: Dividend Cut, Recent Acquisition Positive for Shareholders
-
Biovail Acquisition: UBS Approves, Paradigm Calls It 'A Little Expensive'
-
Biovail 'Still Not Getting the Attention It Deserves' - UBS
-
22 Dividend Stocks with Good Fundamentals
-
Now's the Time to Add Dividend Stocks to Your Portfolio
-
Biovail: Upside Potential, High Dividend Yield
-
Four Stocks with No Debt
-
10 High Cash, High Yield, No Debt Stocks
-
Analysts Express Confidence in Biovail's New Strategy
-
RBC Likes Biovail's Strategy Shift
-
Using the Magic Formula With Dividend Stocks
-
Melnyk's Actions Will Only 'Delay the Inevitable' at Biovail
-
Six Canadian Life Sciences Stocks
-
25 Stocks Benjamin Graham Would Like
-
Biovail Settles Canadian Class Action Suit; Shares Up
-
Biovail: Cloudy Future, but Good Entry-Point for Investors
-
35 Stocks That Ben Graham Would Like Here
-
SEC Nails Biovail: Will 60 Minutes Issue a Retraction?
-
Biovail's Travails and the 'Haunting' Truck Accident
-
Monday's Options Report: C, BAC, BSC, HOV, CX, HA, BVF
-
Is Biovail's Founder Exploring Privatization?
-
Biovail, Corporate Blame-Shifter, in Federal Probe
-
Five Solid Canadian Investments
-
Monday's Options Report: ANR, Biovail, DDUP, GE, Merrill, C
-
Generic Outcome Key to Biovail Dividend
-
Biovail Optimistic On Approval For Depression Drug Launch
-
Goldman's Call On Biovail Is Actionable
-
Biovail Drops On Non-Approval Letter For Smoking Treatment
-
Biovail Chairman 'Retiring': Farewell to a Corporate Blame-Shifter
-
Biovail's Melnyk Is Officially Done
-
Biovail Chairman Melnyk Gets Slammed In Legal Rink
-
The Little Stock that Beats the Market: Joel Greenblatt's Winning Plan
-
Deutsche Bank: Biovail Not Necessarily a 'Sustainable Growth Story'
-
RBC: Strong Quarter, Wellbutrin Deal Ahead for Biovail
-
Analysts Get Bullish on Biovail After Strong Q4
-
Highest-Yielding 'Magic Formula' Stocks: Fording Coal, Precision Drilling
-
Biovail Sued By Former Analyst Who Issued 'Sell' On Stock